TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma

Virchows Archiv

Volumn 460, Issue 6, 2012, Pages 587-600

  Eloy, C ^a,b,c   Santos, J ^c   Cameselle Teijeiro, J ^d   Soares, P ^b,c   Sobrinho Simoes M ^a,b,c  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

BRAF; Papillary thyroid carcinoma; Prognosis; Smad7; TGF beta

Indexed keywords

SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAF GENE; CANCER INVASION; CHILD; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; POORLY CIRCUMSCRIBED PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID PAPILLARY CARCINOMA; WELL CIRCUMSCRIBED PAPILLARY THYROID CARCINOMA;

EID: 84863987340     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1234-y     Document Type: Article

References (56)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon
2. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C (1985) Longterm results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804 (Pubitemid 15173518)
3. Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573 (Pubitemid 27051783)
4. Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso de Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M (2006) PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220 (Pubitemid 43069140)
5. Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P (2005) Molecular pathology of welldifferentiated thyroid carcinomas. Virchows Arch 447:787-793 (Pubitemid 41728865)
6. Castro P, Fonseca E, Magalhães J, Sobrinho-Simões M (2022) Follicular, papillary, and "hybrid" carcinomas of the thyroid. Endocr Pathol 13:313-320
7. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle RM, Fagin JA, Ghossein RA (2010) Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histologic subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23:1191-1200
8. Eloy C, Santos J, Soares P, Sobrinho-Simões M (2011) Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma. Virchows Archiv 459:595-605
9. Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M (2005) Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 446:589-595 (Pubitemid 40922263)
10. Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fiddler JP, Giordano TJ, Biddinger PW, Nikiforov YE (2006) Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216-222 (Pubitemid 43740191)
11. Eloy C, Santos J, Soares P, Sobrinho-Simões M (2011) The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Arch 459:265-276
12. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, Saji M, Ringel MD (2007) Gene expression and functional evidence of epithelial-To-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A 104:2803-2808 (Pubitemid 46327960)
13. Vasko VV, Saji M (2007) Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr Opin Oncol 19:11-17 (Pubitemid 44885594)
14. Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I (2011) Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 64:325-329
15. Jensen K, Patel A, Hoperia V, Larin A, Bauer A, Vasko V (2010) Dynamic changes in e-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer. Exp Ther Med 1:457-462
16. Scarpino S, Cancellario d'Alena F, Di Napoli A, Pasquini A, Marzullo A, Ruco LP (2004) Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J Pathol 202:352-358 (Pubitemid 38325245)
17. Miki H, Kitaichi M, Masuda E, Komaki K, Yamamoto Y, Monden Y (1999) ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma. J Surg Oncol 71:76-82 (Pubitemid 29288483)
18. Fonseca E, Nesland JM, Höie J, Sobrinho-Simões M (1997) Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-Type cytokeratins. Virchows Arch 430:239-245 (Pubitemid 27151935)
19. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM, Baloch ZW (2002) Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126:710-713 (Pubitemid 34602574)
20. Jung CK, Kang YG, Bae JS, Lim DJ, Choi YJ, Lee K-Y (2010) Unique patterns of tumour growth related with the risk of lymph node metastasis in papillary thyroid carcinoma. Mod Pathol 23:1201-1208
21. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91-100 (Pubitemid 37328796)
22. Scarpino S, Stoppacciaro A, Ballerini F, Marchesi M, Prat M, Stella C, Sozzani S, Allavena P, Mantovani A, Ruco LP (2000) Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells. Am J Pathol 156:831-837 (Pubitemid 30626941)
23. Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vigneri R, Gangemi P (1997) In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 82:1615-1620 (Pubitemid 27200444)
24. Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-Associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15:1069-1074
25. Hölting T, Zielke A, Siperstein AE, Clark O, Duh QY (1994) Transforming growth factor-beta1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocrinol Metab 79:806-813
26. Riesco-Eizaguirre G, Rodríguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, Santisteban P (2009) The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 69:8317-8325
27. Kimura ET, Matsuo SE, Ricarte-Filho JC (2007) TGFbeta, activin and SMAD signaling in thyroid cancer. Arq Bras Endocrinol Metab 51:683-689
28. Matsuo SE, Leoni SG, Colquhoun A, Kimura ET (2006) Transforming growth factor-β1 and activin A generate antiproliferative signaling in thyroid cancer cells. J Endocrinol 190:141-150 (Pubitemid 44161069)
29. Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, SalzanoM NYE, Giordano TJ, Ghossein RA, Fagin JA (2011) Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. Oncogene 30:3153-3162
30. Massagué J (1998) TGFb-signal transduction. Annu Rev Biochem 67:753-791
31. ten Dijke P, Hill CS (2004) New insights into TGF-β-Smad signaling. Trends Biochem Sci 29:265-273
32. Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078-2093 (Pubitemid 46211385)
33. Nicolussi A, D'Inzeo S, Santulli M, Colletta G, Coppa A (2003) TGF-beta control of rat thyroid follicular cells differentiation. Mol Cell Endocrinol 207:1-11 (Pubitemid 37102948)
34. Morris JC 3rd, Ragnanathan G, Hay ID, Nelson RE, Jiang NS (1988) The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 123:1385-1394
35. Franzén A, Piek E, Westermark B, ten Dijke P, Heldin N-E (1999) Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocytes growth and function. Endocrinology 140:4300-4310 (Pubitemid 30647129)
36. Bravo SB, Pampín S, Cameselle-Teijeiro J, Carneiro C, Domínguez F, Barreiro F, Alvarez CV (2003) TGF-β-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-αB activation. Oncogene 22:7819-7830 (Pubitemid 37485541)
37. Pisarev MA, Thomasz L, Juvenal GJ (2009) Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid 19:881-892
38. Kimura ET, Kopp P, Zbaeren J, Asmis LM, Ruchti C, Maciel RM, Studer H (1999) Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study. Thyroid 9:119-125 (Pubitemid 29115531)
39. Morosini PP, Taccaliti A, Montironi R, Scarpelli M, Diamanti L, Simonella G, Mancini V, Petrelli MD, Mantero F (1996) TGFbeta1 immunohistochemistry in goiter: comparison of patients with recurrence or no recurrence. Thyroid 6:417-422 (Pubitemid 26398646)
40. Matsuo SE, Fiore AP, Siguematu SM, Ebina KN, Fruglietti CU, Ferro MC, Kulcsar MA, Kimura ET (2010) Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues. Arq Bras Endocrinol Metab 54:406-412
41. Imamura Y, Jin L, Grande JP, Li C-Y, Zheng TR, Erickson LA, Lloyd RV (1998) Analysis of TGF-α and TGF-α-RII in thyroid neoplasms from the United States, Japan, and China. Endocr Pathol 9:209-216 (Pubitemid 28536796)
42. Jasani B, Wyllie FS, Wright PA, Lemoine NR, Williams ED, Wynford-Thomas D (1990) Immunocytochemically detectable TGF-β associated with malignancy in thyroid epithelial neoplasia. Growth Factors 2:149-155 (Pubitemid 20057752)
43. Lloyd RV, Ferreiro JA, Jin L, Sebo TJ (1997) TGFB, TGFB receptors, Ki-67, and p27(Kip)l expression in papillary thyroid carcinomas. Endocr Pathol 8:293-300 (Pubitemid 127718207)
44. Cerutti JM, Ebina KN, Matsuo SE, Martins L, Maciel RM, Kimura ET (2003) Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines. J Endocrinol Invest 26:516-521 (Pubitemid 36998699)
45. D'Inzeo S, Nicollussi A, Ricci A, Mancini P, Porcellini A, Nardi F, Coppa A (2010) Role of reduced expression of SMAD4 in papillary thyroid carcinoma. J Mol Endocrinol 45:229-244
46. Massagué J (2008) TGFbeta in cancer. Cell 134:215-230
47. Nicolussi A, D'Inzeo S, Gismondi A, Coppa A (2006) Reduction of invasive potential in K-ras-Transformed thyroid cells by restoring of TGF-beta pathway. Clin Exp Metastasis 23:237-248
48. Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11:23-35 (Pubitemid 30169723)
49. Asmis LM, Kaempf J, Von Gruenigen C, Kimura ET, Wagner HE, Studer H (1996) Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-b1 (TGF-β1). J Endocrinol 149:485-496 (Pubitemid 26196078)
50. Heldin NE, Bergström D, Hermansson A, Bergenstrahle A, Nakao A, Westermark B, ten Dijke P (1999) Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensivity in carcinoma cells. Mol Cell Endocrinol 153:79-90 (Pubitemid 29339159)
51. Coppa A, Mincione G, Mammarella S, Ranieri A, Colletta G (1995) Epithelial rat thyroid cell clones, escaping from transforming growth factor b negative growth control, are still inhibited by this factor in the ability to trap iodine. Cell Growth Differ 6:281-290
52. Mesa C Jr, Mirza M, Mitsutake N, Sartor M, Medvedovic M, Tomlinson C, Knauf JA, Weber GF, Fagin JA (2006) Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling. Cancer Res 66:6521-6529 (Pubitemid 44085606)
53. Lazzareschi D, Nardi F, Turco A, Ottini L, Dámico C, Mariani-Constantini R, Gulino A, Coppa A (2005) A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours. Oncogene 24:5344-5354 (Pubitemid 43080104)
54. Itóh S, Landström M, Hermansson A, Itoh F, Heldin CH, Heldin NE, ten Dijke P (1998) Transforming growth factor beta1 induces nuclear export of inhibitory Smad7. J Biol Chem 273:29195-29201 (Pubitemid 28507620)
55. Piana S, Frasoldati A, Di Felice E, Gardini G, Tallini G, Rosai J (2010) Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol 34:868-872
56. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404 (Pubitemid 37452745)